Singapore, Oct. 22 -- Mubadala Bio has signed a strategic partnership with Marcyrl Pharmaceutical Industries (Marcyrl Group) to localise a broad portfolio of women's health, fertility and respiratory products in the UAE.

Dr Essam Mohamed, Group Chief Executive Officer of Mubadala Bio, and Dr George Saad, Chief Executive Officer of Marcyrl Group, signed the agreement at the Future Health Summit in Abu Dhabi.

The partnership will bring a portfolio of women's health and fertility medicines to the UAE, supporting women across key stages of reproductive health, from fertility and pregnancy through to childbirth, alongside treatments for common gynecological and hormonal conditions.

The respiratory portfolio will address a range of acute and...